Kymera | Investor Presentation Deck | 60 slides · page 18 of 60
The slide compares cytokine inhibition efficacy in Healthy Subjects (MAD3), AD patients, and HS patients using two different stimulation methods (LPS and R848).
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 7/7
chart 2/2 disclaimer 1/1 legend 1/1 table 2/2 title 1/1
Components 7
bar-grouped bar-grouped disclaimer legend data data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.